Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.
Vignal C, Uretsky S, Fitoussi S, Galy A, Blouin L, Girmens JF, Bidot S, Thomasson N, Bouquet C, Valero S, Meunier S, Combal JP, Gilly B, Katz B, Sahel JA. Vignal C, et al. Among authors: valero s. Ophthalmology. 2018 Jun;125(6):945-947. doi: 10.1016/j.ophtha.2017.12.036. Epub 2018 Feb 14. Ophthalmology. 2018. PMID: 29426586 Free article. Clinical Trial. No abstract available.
Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial.
Bouquet C, Vignal Clermont C, Galy A, Fitoussi S, Blouin L, Munk MR, Valero S, Meunier S, Katz B, Sahel JA, Thomasson N. Bouquet C, et al. Among authors: valero s. JAMA Ophthalmol. 2019 Apr 1;137(4):399-406. doi: 10.1001/jamaophthalmol.2018.6902. JAMA Ophthalmol. 2019. PMID: 30730541 Free PMC article. Clinical Trial.
Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy.
Gonzales E, Gardin A, Almes M, Darmellah-Remil A, Seguin H, Mussini C, Franchi-Abella S, Duché M, Ackermann O, Thébaut A, Habes D, Hermeziu B, Lapalus M, Falguières T, Combal JP, Benichou B, Valero S, Davit-Spraul A, Jacquemin E. Gonzales E, et al. Among authors: valero s. JHEP Rep. 2023 Jul 13;5(10):100844. doi: 10.1016/j.jhepr.2023.100844. eCollection 2023 Oct. JHEP Rep. 2023. PMID: 37701337 Free PMC article.
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort.
Puerta R, Cano A, García-González P, García-Gutiérrez F, Capdevila M, de Rojas I, Olivé C, Blázquez-Folch J, Sotolongo-Grau O, Miguel A, Montrreal L, Martino-Adami P, Khan A, Orellana A, Sung YJ, Frikke-Schmidt R, Marchant N, Lambert JC, Rosende-Roca M, Alegret M, Fernández MV, Marquié M, Valero S, Tárraga L, Cruchaga C, Ramírez A, Boada M, Smets B, Cabrera-Socorro A, Ruiz A. Puerta R, et al. Among authors: valero s. Int J Mol Sci. 2024 Dec 31;26(1):286. doi: 10.3390/ijms26010286. Int J Mol Sci. 2024. PMID: 39796148 Free PMC article.
FACEmemory®, an Innovative Self-Administered Online Memory Assessment Tool.
Alegret M, Blazquez-Folch J, Pérez A, Ortega G, Espinosa A, Muñoz N, Sanabria A, García-Gutiérrez F, Alarcon-Martin E, Rosende-Roca M, Vargas L, Tartari JP, Rentz DM, Valero S, Ruiz A, Boada M, Marquié M. Alegret M, et al. Among authors: valero s. J Clin Med. 2024 Nov 29;13(23):7274. doi: 10.3390/jcm13237274. J Clin Med. 2024. PMID: 39685733 Free PMC article.
Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.
Morató X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, Montrreal L, Rosende-Roca M, García-González P, Olivé C, García-Gutiérrez F, Blázquez J, Miguel A, Núñez-Llaves R, Pytel V, Alegret M, Fernández MV, Marquié M, Valero S, Cavazos JE, Mañes S, Boada M, Cabrera-Socorro A, Ruiz A. Morató X, et al. Among authors: valero s. Brain Behav Immun Health. 2024 Nov 16;42:100899. doi: 10.1016/j.bbih.2024.100899. eCollection 2024 Dec. Brain Behav Immun Health. 2024. PMID: 39640195 Free PMC article.
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.
Tonietto M, Sotolongo-Grau O, Roé-Vellvé N, Bullich S, Tartari JP, Sanabria Á, García-Sánchez A, Borroni E, Galli C, Pérez-Martínez E, Castell-Conesa J, Roca I, Tárraga L, Ruiz A, Stephens AW, Boada M, Klein G, Marquié M; FACEHBI study group; AMYPAD consortium. Tonietto M, et al. Alzheimers Res Ther. 2024 Nov 28;16(1):257. doi: 10.1186/s13195-024-01622-5. Alzheimers Res Ther. 2024. PMID: 39605030 Free PMC article.
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.
Castilla-Martí L, García-Sánchez A, Martínez J, Rosende-Roca M, Vargas L, Tartari JP, Casales F, Rodríguez JN, Bein N, Alegret M, Ortega G, Espinosa A, Sanabria Á, Pérez-Cordón A, Muñoz N, García-Gutiérrez F, Blazquez-Folch J, Miguel A, de Rojas I, García-González P, Puerta R, Olivé C, Capdevila M, Muñoz-Morales Á, Bayón-Buján P, Cano A, Fernández V, Valero S, Tárraga L, Ruiz A, Boada M, Castilla-Martí M, Marquié M. Castilla-Martí L, et al. Among authors: valero s. Alzheimers Res Ther. 2024 Nov 16;16(1):249. doi: 10.1186/s13195-024-01616-3. Alzheimers Res Ther. 2024. PMID: 39550564 Free PMC article.
224 results